Department of Geriatric Medicine, Fujian Provincial Hospital, Shengli Clinical Medical College, Fujian Medical University, Fuzhou, Fujian, China.
Department of Geriatric Medicine, Fujian Provincial Hospital, Shengli Clinical Medical College, Fujian Medical University, Fuzhou, Fujian, China; Department of Endocrinology, Fujian Provincial Hospital, Shengli Clinical Medical College, Fujian Medical University, Fuzhou, Fujian, China.
Biochem Biophys Res Commun. 2023 Nov 19;682:148-155. doi: 10.1016/j.bbrc.2023.09.075. Epub 2023 Oct 4.
Silencing type information regulator homolog 1 (SIRT1) is a class of nicotinamide adenine dinucleotide (NAD) dependent deacetylases, which is the convergence point of important physiological processes in vivo, namely, osteoblast aging, energy metabolism, and bone remodeling. To verify whether the O-acetylglucosamine (O-GlcNAc) modification of SIRT1 in the nucleus of osteoblasts enhances its deacetylase activity under stress and protects osteoblasts through the RANK/RANKL signaling pathway by collagen deacetylation. The R language and online data research identified SIRT1 as being involved in bone metabolism. Enrichment analysis showed that SIRT1 is involved in osteoblast transcription, apoptosis, and deacetylation pathways. Interactive Immuno-blotting and immunofluorescence experiments revealed that SIRT1 and O-glycosylation catalytic enzyme (OGT) were localized in the nucleus. Mass Spectrometry analysis showed that O-glycosylation occurred on the asparagine at the 346th position of SIRT1, and N346 was located in the central domain of SIRT1. Furthermore, the protein structure analysis of PyMol also proved that the OGT binding region was in the central domain of SIRT1. Under physiological conditions, both wtSIRT1 and SIRT1 can inhibit RANKL-mediated transcriptional activation. The RT-PCR detection results showed that wtSIRT1 reduced RANKL transcription under the conditions of apoptotic agent treatment. The finding that SIRT1 can regulate the physiological process of bone remodeling through the RANK/RANKL signaling pathway in osteoblasts under stress. The O-glycosylation and deacetylation activity of SIRT1 significantly increased, regulating the balance between osteoblast survival and apoptosis by deacetylation of key proteins such as RANKL.
沉默信息调节因子同源物 1(SIRT1)是一类烟酰胺腺嘌呤二核苷酸(NAD)依赖性去乙酰化酶,它是体内重要生理过程的交汇点,即成骨细胞衰老、能量代谢和骨重塑。为了验证核内成骨细胞 SIRT1 的 O-乙酰葡萄糖胺(O-GlcNAc)修饰是否能增强其在应激下的去乙酰化酶活性,并通过胶原去乙酰化作用通过 RANK/RANKL 信号通路保护成骨细胞。R 语言和在线数据分析确定 SIRT1 参与骨代谢。富集分析表明 SIRT1 参与成骨细胞转录、凋亡和去乙酰化途径。交互免疫印迹和免疫荧光实验表明 SIRT1 和 O-糖基化催化酶(OGT)定位于核内。质谱分析表明 SIRT1 的第 346 位天冬酰胺发生 O-糖基化,N346 位于 SIRT1 的中心结构域。此外,PyMol 的蛋白质结构分析也证明了 OGT 结合区域位于 SIRT1 的中心结构域。在生理条件下,wtSIRT1 和 SIRT1 均可抑制 RANKL 介导的转录激活。RT-PCR 检测结果表明,wtSIRT1 在凋亡剂处理条件下降低了 RANKL 的转录。该研究发现,SIRT1 可以通过 RANK/RANKL 信号通路调节应激下成骨细胞的骨重塑生理过程。SIRT1 的 O-糖基化和去乙酰化活性显著增加,通过去乙酰化 RANKL 等关键蛋白调节成骨细胞存活和凋亡之间的平衡。